Full results from two Lilly trials of the novel triple hormone receptor agonist show reductions in A1c, osteoarthritis knee pain, and obstructive sleep apnea.

Patients with obesity and type 2 diabetes have more favorable QOL outcomes taking a GLP-1 than those with either condition alone or with multiple comorbidities.

More nurses regularly take on second shifts but as the practice becomes normalized, is this best for patients?

A pilot study shows that a urine-based metabolite panel accurately distinguishes children with autism from typically ...

Phase 3 data on sunvozertinib for EGFR exon 20 insertions and sacituzumab tirumotecan plus pembrolizumab for PD-L1-positive ...

Both T1D and T2D are linked to a higher incidence of subtrochanteric or femoral shaft and hip fractures, but after adjusting ...

New research suggests that time and aging change how people deal with regrets. Here’s what it could mean for doctors.

The first known analysis of pooled worldwide population-based data on dementia with Lewy bodies shows incidence is higher ...

Weekly subcutaneous injections of the novel B-cell inhibitor obexelimab significantly reduces disease flares and lowers toxic ...

A new study in mice finds that cannabis extracts improve glucose regulation by improving communication between fat cells and ...

Without a robust national surveillance system and confidential reporting, it’s impossible to know where Canada stands on ...

A 14-month-old female with a history of atopy presented with an 8-month history of a persistent, non-tender, non-bleeding ...